[1]
2025. Clinical Evaluation of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido thiazolyl resorcinol) in Prevention of UVB-induced Hyperpigmentation. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s545. DOI:https://doi.org/10.25251/skin.10.supp.545.